NCT03035409View on ClinicalTrials.gov

Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

December 27, 2019

Study Completion Date

February 28, 2026

Conditions
Advanced Malignant Solid NeoplasmC-Reactive Protein MeasurementCancer FatigueMetastatic Malignant Solid NeoplasmRecurrent Malignant Solid NeoplasmWeight Loss
Interventions
DRUG

Anamorelin Hydrochloride

Given PO

BEHAVIORAL

Exercise Intervention

Undergo physical activity

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Nutritional Assessment

Undergo nutritional counseling

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03035409 - Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors | Biotech Hunter | Biotech Hunter